智能定制平台在影像中心用药安全一体化管理模式的构建与应用

Construction and Application of Intelligent Customization Platform in the Integrated Management Model of Medication Safety in the Imaging Center

摘要: 目的：基于智能定制平台信息系统，构建影像中心用药安全一体化管理模式，并对其在增强患者检查过程中的应用效果进行初步评价。方法：组建用药安全管理团队，构建影像中心用药安全一体化管理系统，涵盖风险评估、检查前、检查后、不良反应处理以及延迟性不良反应处理五个模块。选取2024年1月至12月期间江西省某三级甲等综合医院行增强检查的患者、用药安全管理团队成员以及影像中心医务人员80名作为研究对象。比较系统应用前(2024年1月~6月)与应用后(2024年7月~12月)的影像中心用药安全一体化管理执行效率，以及系统的可用性和满意度。结果：一体化管理模式应用后，患者一次性检查成功率高于对照组，用药不良反应发生率低于对照组，不良反应处理及时率高于对照组，总满意度高于对照组，差异具有统计学意义(P < 0.05)。系统的可用性得分处于较高水平，在满意度各个维度中，包括易用性、安全性、准确性、适用性、及时性和有效性等，所有得分均表现为高水平。结论：构建的影像中心用药安全管理一体化模式有效优化了用药安全管理流程，促进了护患之间的即时有效沟通，提高了患者用药安全性。初步应用结果显示，该模式具有较高的准确性和良好的可用性，为影像中心的用药安全管理提供了有效的实践依据。

Abstract: Objective: To develop an integrated medication safety management model for imaging centers based on an intelligent customization platform information system, and to conduct a preliminary evaluation of its effectiveness in enhancing patient outcomes during contrast-enhanced examinations. Methods: A medication safety management team was established, and an integrated medication safety management system for the imaging center was constructed. The system consisted of five modules: risk assessment, pre-examination management, post-examination management, adverse reaction handling, and delayed adverse reaction management. Patients who underwent contrast-enhanced examinations, members of the medication safety management team, and 80 imaging center medical staff from a tertiary-level Class A general hospital in Jiangxi Province between January and December 2024 were included. We compared the execution efficiency of integrated medication safety management in the imaging center before (January-June 2024) and after (July-December 2024) system implementation, as well as system usability and satisfaction. Results: After the application of integrated management model, the success rate of one-time examination was higher than that of the control group, the incidence of adverse drug reactions was lower than that of the control group, the timely rate of adverse drug reactions was higher than that of the control group, and the total satisfaction was higher than that of the control group, with statistical significance (P < 0.05). The usability score of the system is at a high level, and in all dimensions of satisfaction, including usability, safety, accuracy, applicability, timeliness and effectiveness, all the scores are at a high level. Conclusion: The integrated medication safety management model effectively optimized the workflow of medication safety management in the imaging center and promoted timely and effective nurse-patient communication, thereby improving patient medication safety. Preliminary findings indicate that the model demonstrates high accuracy and favorable usability, providing strong practical support for medication safety management in imaging centers.